- Home
- PBYI vs NKSH Comparison
PBYI vs NKSH Comparison
Compare PBYI & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- NKSH
- Stock Information
- Founded
- PBYI 2010
- NKSH 1891
- Country
- PBYI United States
- NKSH United States
- Employees
- PBYI N/A
- NKSH N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- NKSH Major Banks
- Sector
- PBYI Health Care
- NKSH Finance
- Exchange
- PBYI Nasdaq
- NKSH Nasdaq
- Market Cap
- PBYI 153.2M
- NKSH 182.9M
- IPO Year
- PBYI N/A
- NKSH N/A
- Fundamental
- Price
- PBYI $2.92
- NKSH $30.80
- Analyst Decision
- PBYI Strong Buy
- NKSH Strong Buy
- Analyst Count
- PBYI 1
- NKSH 1
- Target Price
- PBYI $7.00
- NKSH $38.00
- AVG Volume (30 Days)
- PBYI 416.5K
- NKSH 14.4K
- Earning Date
- PBYI 11-07-2024
- NKSH 10-24-2024
- Dividend Yield
- PBYI N/A
- NKSH 4.92%
- EPS Growth
- PBYI 492.79
- NKSH N/A
- EPS
- PBYI 0.47
- NKSH 1.44
- Revenue
- PBYI $243,569,000.00
- NKSH $43,450,000.00
- Revenue This Year
- PBYI N/A
- NKSH N/A
- Revenue Next Year
- PBYI N/A
- NKSH $14.93
- P/E Ratio
- PBYI $6.26
- NKSH $21.26
- Revenue Growth
- PBYI 6.30
- NKSH N/A
- 52 Week Low
- PBYI $2.23
- NKSH $26.50
- 52 Week High
- PBYI $7.73
- NKSH $35.93
- Technical
- Relative Strength Index (RSI)
- PBYI 47.45
- NKSH 47.98
- Support Level
- PBYI $2.82
- NKSH $30.80
- Resistance Level
- PBYI $3.12
- NKSH $32.03
- Average True Range (ATR)
- PBYI 0.20
- NKSH 0.89
- MACD
- PBYI -0.03
- NKSH -0.08
- Stochastic Oscillator
- PBYI 14.71
- NKSH 42.01
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.